Javascript must be enabled to continue!
A STUDY ON DIALYSATE GLUCOSE CONCENTRATION IN PATIENTS WITH CONTINUOUS AMBULATORY PERITONEAL DIALYSIS
View through CrossRef
Background: Glucose-based peritoneal dialysis (PD) is the predominantly used dialysate in PD patients. Glucose absorption in peritoneal dialysis (PD) patients may contribute to adverse metabolic complications. The impact of high peritoneal dialysate glucose concentration (PDGC) on all-cause as well as cardiovascular disease (CVD) mortality in peritoneal dialysis (PD) patients is unclear. The current researchs widely applied formulae may be not suitable for estimation of glucose absorption in continuous ambulatory peritoneal dialysis (CAPD) patients. Objective: This study examined the actual glucose absorption in a cohort of CAPD patients and compared the results with estimates from three current formulae. Our study provides an overview of glucose associated metabolic complications and to investigate the impact of high glucose in
dialysate on our CAPD patients. Methods: We conducted a survey of glucose absorption of a cohort of 56 CAPD patients and compared actual dialysate glucose absorbed with the one of K/DOQI formula, Grodstein formula, or a percentage estimate of 60%. Results: The total dialysate glucose infused each day varied from 108.8 to 181.6 g/day with average of 130±19.6 g, with the mean glucose concentration in dialysate is 1.79%. The average of glucose absorbed was 83.2±24.3 g/day (ranging from 28.6 to 145.2 g) by actual measurements. The mean absorption rate was 64.1% (ranging from 22.6% to 99.6%). There are no significant differences between 4 methods estimating glucose absorption in CAPD patients. There are strong correlations between glucose concentration using in PD patients with levels of total cholesterol, triglyceride, urea, creatinine and uric acid. Only triglyceride concentration associated with glucose absorption from dialysate. Conclusions:
The applications of current estimating methods may have limitations. The actual measurement providesdietitians and doctors more exact information of absorbed glucose and energy compared to the current estimating methods.
Key words: dialysate, Glucose absorption, peritoneal dialysis, continuous ambulatory peritoneal dialysis, acid uric, triglyceride
Hue University of Medicine and Pharmacy
Title: A STUDY ON DIALYSATE GLUCOSE CONCENTRATION IN PATIENTS WITH CONTINUOUS AMBULATORY PERITONEAL DIALYSIS
Description:
Background: Glucose-based peritoneal dialysis (PD) is the predominantly used dialysate in PD patients.
Glucose absorption in peritoneal dialysis (PD) patients may contribute to adverse metabolic complications.
The impact of high peritoneal dialysate glucose concentration (PDGC) on all-cause as well as cardiovascular disease (CVD) mortality in peritoneal dialysis (PD) patients is unclear.
The current researchs widely applied formulae may be not suitable for estimation of glucose absorption in continuous ambulatory peritoneal dialysis (CAPD) patients.
Objective: This study examined the actual glucose absorption in a cohort of CAPD patients and compared the results with estimates from three current formulae.
Our study provides an overview of glucose associated metabolic complications and to investigate the impact of high glucose in
dialysate on our CAPD patients.
Methods: We conducted a survey of glucose absorption of a cohort of 56 CAPD patients and compared actual dialysate glucose absorbed with the one of K/DOQI formula, Grodstein formula, or a percentage estimate of 60%.
Results: The total dialysate glucose infused each day varied from 108.
8 to 181.
6 g/day with average of 130±19.
6 g, with the mean glucose concentration in dialysate is 1.
79%.
The average of glucose absorbed was 83.
2±24.
3 g/day (ranging from 28.
6 to 145.
2 g) by actual measurements.
The mean absorption rate was 64.
1% (ranging from 22.
6% to 99.
6%).
There are no significant differences between 4 methods estimating glucose absorption in CAPD patients.
There are strong correlations between glucose concentration using in PD patients with levels of total cholesterol, triglyceride, urea, creatinine and uric acid.
Only triglyceride concentration associated with glucose absorption from dialysate.
Conclusions:
The applications of current estimating methods may have limitations.
The actual measurement providesdietitians and doctors more exact information of absorbed glucose and energy compared to the current estimating methods.
Key words: dialysate, Glucose absorption, peritoneal dialysis, continuous ambulatory peritoneal dialysis, acid uric, triglyceride.
Related Results
Assessment of implementation of the Pradhan Mantri national dialysis Programme in Hospitals in Delhi
Assessment of implementation of the Pradhan Mantri national dialysis Programme in Hospitals in Delhi
Background: Annual-demand for haemodialysis-sessions in India is 3.4 Crores. To make Renal-care-services affordable to APL and free to BPL, Ministry of Health and Family Welfare la...
Hyaluronan reduces colitis-induced intraperitoneal inflammation during peritoneal dialysis
Hyaluronan reduces colitis-induced intraperitoneal inflammation during peritoneal dialysis
Background: Peritoneal dialysis induces the inflammatory response within the peritoneal cavity, which contributes to the progressive damage of the peritoneum. Due to close contact ...
Advances in Peritoneal Dialysis: Towards Improved Efficacy and Safety
Advances in Peritoneal Dialysis: Towards Improved Efficacy and Safety
<b>Background:</b> The success of peritoneal dialysis on the short-term is mainly dependent on the prevention of infectious and technical complications. The mid-term re...
Abstract B140: Autologous human growing tumor model and its immunological relevance for cancer immunology research
Abstract B140: Autologous human growing tumor model and its immunological relevance for cancer immunology research
Abstract
Background: Tumors grow in accordance with immunoediting. If we can see the changes of immune characteristics in the microenvironment during tumor growth, w...
FC 117TIME TRENDS IN PROBABILITY OF STARTING HOME DIALYSIS OVER A 20 YEAR PERIOD: A DUTCH REGISTRY STUDY
FC 117TIME TRENDS IN PROBABILITY OF STARTING HOME DIALYSIS OVER A 20 YEAR PERIOD: A DUTCH REGISTRY STUDY
Abstract
Background and Aims
A growing number of patients suffers from End Stage Kidney Disease(ESKD), causing a logistical and ...
Impact of a Low-Glucose Peritoneal Dialysis Regimen on Fibrosis and Inflammation Biomarkers
Impact of a Low-Glucose Peritoneal Dialysis Regimen on Fibrosis and Inflammation Biomarkers
Background The impact of a low-glucose peritoneal dialysis (PD) regimen on biomarkers of peritoneal inflammation, fibrosis and membrane integrity remains to be investigated. Method...
MO702DIFFERENCES IN HOSPITALISATION BETWEEN PERITONEAL DIALYSIS AND IN-CENTRE HAEMODIALYSIS PATIENTS
MO702DIFFERENCES IN HOSPITALISATION BETWEEN PERITONEAL DIALYSIS AND IN-CENTRE HAEMODIALYSIS PATIENTS
Abstract
Background and Aims
End stage kidney disease (ESKD) and dialysis treatment are associated with high morbidity, frequent...
Continuous Flow Peritoneal Dialysis: Solution Formulation and Biocompatibility
Continuous Flow Peritoneal Dialysis: Solution Formulation and Biocompatibility
When peritoneal dialysis was introduced several years ago an important alternative dialysis therapy to hemodialysis was made available for the treatment of end‐stage chronic diseas...

